Ai Robotics (247A) Q4 2026 earnings summary

Executive summary

• FY2026 net sales rose 106.7% YoY to ¥29.359bn; operating profit increased 53.3% to ¥3.802bn and net profit 55.9% to ¥2.654bn.

• Growth reflected domestic and inbound beauty demand, brand-building, expanded products and nationwide Straine distribution.

• FY2027 guidance targets ¥56–60bn net sales and ¥7.5–10bn operating profit; BJC consolidation and channel transformation support growth.

• FY2029 targets are ¥220bn net sales, ¥40bn operating profit and ¥1tn market capitalization.

Financial highlights

• FY2026 gross profit was ¥21.537bn, up 93.3% YoY; ordinary profit was ¥3.780bn, up 56.0%.

• Operating profit achieved 79.2% of the ¥4.8bn plan; the ¥1.0bn shortfall was attributed to wholesale-transition investment, including ¥1.8bn in in-store POS-data marketing expenses.

• FY2026 non-consolidated SG&A was ¥17.735bn versus ¥8.662bn a year earlier.

• At Mar. 31, 2026, total assets were ¥18.43bn, net assets ¥6.05bn and cash and equivalents ¥3.99bn; interest-bearing liabilities rose ¥6.33bn YoY.

Outlook and guidance

• FY2027 consolidated guidance: net sales ¥56–60bn (+90.7% to +104.4%) and operating profit ¥7.5–10bn (+97.2% to +163.0%).

• Adjusted operating profit is forecast at ¥9.5–12bn; adjusted EBITDA at ¥9.5–12bn (+146.7% to +211.7%) and adjusted profit at ¥5.9–7.4bn (+122.2% to +178.7%).

• Q1 FY2027 is expected to be loss-making as strategic investment in the store-wholesale transition continues.

• FY2027 brand sales/gross-profit KPIs: Yunth ¥20bn/¥14bn, Brighte ¥15bn/¥9.7bn, Straine ¥6bn/¥3.7bn and BJC ¥15bn/¥8.6bn.

• Guidance reflects BJC acquisition effects and planned synergies from product development, channel expansion and SELL software; adjusted metrics exclude specified M&A costs and amortization.